Longboard Pharmaceuticals...

NASDAQ: LBPH · Real-Time Price · USD
59.98
null (null%)
At close: Nov 29, 2024, 7:00 PM

Longboard Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
27.61M 14.6M 54.4M 14.33M 23.91M 19.5M 25.12M 10.78M 18.75M 27.72M 35.04M 66.35M 75.46M 90.86M 120.85M
Short-Term Investments
260.84M 290.27M 266.65M 34.17M 32.11M 43.54M 51.01M 56.81M 58.57M 59.7M 61.09M 40.38M 37.1M 27.98M n/a
Long-Term Investments
n/a 244K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
244K n/a 244K n/a 36K 35K 35K 33K 33K n/a 33K 33K 33K 33K n/a
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
4.58M 3.93M 2.4M 1.72M 2.31M 2.54M 2.83M 2.25M 2.47M 2.73M 4.04M 1.66M 2.74M 1.85M 2.78M
Total Current Assets
293.03M 308.81M 323.44M 50.22M 58.32M 65.59M 78.96M 69.84M 79.79M 90.15M 100.16M 108.38M 115.3M 120.69M 123.63M
Property-Plant & Equipment
3.73M 3.86M 3.98M 476K 505K 596K 689K 745K 834K 367K 451K 535K 616K n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
3.98M 4.1M 4.22M 476K 541K 631K 724K 778K 867K 367K 484K 568K 649K 33K n/a
Total Assets
297M 312.9M 327.67M 50.7M 58.86M 66.22M 79.68M 70.62M 80.66M 90.51M 100.64M 108.95M 115.95M 120.72M 123.63M
Account Payables
1.13M 2.48M 1.04M 1M 363K 1.94M 283K 1.31M 575K 602K 1.36M 1.03M 891K 915K 2.02M
Deferred Revenue
n/a n/a n/a n/a -394K -375K n/a n/a n/a n/a n/a 3.74M 2.47M n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
16.92M 20K 50K 4.92M 30K 20K 50K 34K 31K 31K n/a 168K n/a n/a 275K
Total Current Liabilities
18.35M 14.74M 10.29M 9.77M 6.71M 7.9M 7.24M 8.76M 8.15M 7.54M 6.68M 5.44M 4.02M 3.27M 4.04M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
3.47M 3.57M 3.67M n/a 108K 214K 312K 382K 469K 965K 94K 185K 275K n/a n/a
Total Liabilities
21.82M 18.3M 13.96M 9.77M 6.82M 8.12M 7.55M 9.15M 8.62M 7.54M 6.78M 5.63M 4.3M 3.27M 4.04M
Total Debt
3.73M 3.86M 3.98M 475K 502K 589K 683K 740K 829K 363K 444K 524K 603K n/a n/a
Common Stock
3K 3K 3K 2K 2K 2K 2K 1K 1K 1K 1K 1K 1K 1K 1K
Retained Earnings
-201.88M -177.34M -155.55M -140.56M -125.53M -112.6M -97.6M -86.14M -74.8M -63.2M -51.79M -42.2M -33.42M -27.08M -20.1M
Comprehensive Income
700K -475K -366K -78K -181K -290K -421K -692K -915K -784K -596K -164K -24K -34K -123.63M
Shareholders Equity
275.19M 294.6M 313.71M 40.92M 52.04M 58.11M 72.13M 61.47M 72.04M 82.97M 93.86M 103.32M 111.65M 117.45M 119.59M
Total Investments
260.84M 290.52M 266.65M 34.17M 32.11M 43.54M 51.01M 56.81M 58.57M 59.7M 61.09M 40.38M 37.1M 27.98M n/a